The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and Its Diagnostic Components in Patients With Mixed Dyslipidemia

OBJECTIVE: To compare fenofibric acid (FA) + statin to respective monotherapies on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemia. RESEARCH DESIGN AND METHODS: Post hoc analysis of over 2,000 metabolic syndrome patients administered either FA +...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bays, Harold E., Roth, Eli M., McKenney, James M., Kelly, Maureen T., Thakker, Kamlesh M., Setze, Carolyn M., Obermeyer, Katie, Sleep, Darryl J.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2010
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2928374/
https://ncbi.nlm.nih.gov/pubmed/20573750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-0357
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars